Biotech Startups

Bio Design Lab uses synthetic biology to engineer viral vector components, offering retroviral and lentiviral vectors designed to shift transgene integration away from proto-oncogenes for improved safety and enhanced transduction efficiency. Its vectors support gene therapies, cell therapies (including T and NK cells), vaccine platforms, and protein-producing cell lines.

1 investor

Biodesix is a diagnostic solutions company that develops and provides advanced diagnostic tests, with a focus on lung disease and cancer, to support clinical decisions and personalized patient care. It also offers custom diagnostic development services to biopharmaceutical, life sciences, and research institutions.

1 investor

Biodimension develops tissue engineering and non-animal testing methods including in-vitro platforms, biofabricated tissues, and computational models for pharmaceutical, personal care, and agrochemical industries. The company provides alternatives to animal testing for preclinical research and regenerative medicine applications.

1 investor

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

BioDlink is a contract development and manufacturing organization (CDMO) providing drug development and manufacturing services for biopharmaceutical companies, with specialization in antibody-drug conjugates (ADCs).

1 investor

Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.

1 investor

Biodrive (Evolv) develops biomimetic oral peptides engineered to activate the body's own signaling pathways, including a daily tablet that targets GLP-1 and GIP receptors for metabolic health and weight management. The company also offers an oral peptide biomimetic for hair, positioning its products as an alternative to supplements and drugs for consumers seeking metabolic and appearance support.

1 investor

Bioefekts is a Latvian agricultural biotech company that develops microbial-based soil amendments and plant growth products for greenhouse and field cultivation, including nitrogen-fixing bacteria, phosphorus-solubilizing microbes, and antifungal agents.

1 investor

Bioelectrix develops a novel electrical stimulation technology to accelerate wound healing by delivering stable, controlled electrical signals to tissue. The company targets diabetic foot ulcers and other chronic wounds, with initial focus on patients for whom small wounds can become life-threatening complications.

1 investor

Bioelectronica develops hardware and software tools for accelerated antibody discovery using single-cell protein secretion sorting combined with AI-driven sequence analysis. The company serves research institutions and biotech firms in the life sciences industry.

1 investor

Bioemtech provides in vitro cell-based assays and laboratory services for drug discovery and stem cell therapy applications, utilizing cell lines and standardized protocols to measure cytotoxicity, biological activity, and biochemical mechanisms for pharmaceutical research.

1 investor

BioFirst Group develops biological crop protection, soil and crop health, pollination, and biostimulant solutions for greenhouse growers and open-field crop farmers worldwide. It operates four brands serving the horticulture and open-field agriculture markets with biopesticides, biofertilizers, inoculants, and natural pollination products.

1 investor

BioFront Technologies manufactures ELISA kits and lateral flow devices for detecting and quantifying food allergens, serving food manufacturers and regulators in the food industry.

1 investor

BioGaia develops and markets probiotic supplements for consumer health, with a particular focus on infant nutrition. The company manufactures most products in-house in Sweden and distributes globally to healthcare professionals and consumers.

1 investor

Biogaran is a French pharmaceutical brand focused on generic medicines and health products, offering health-related content and patient support initiatives. It serves patients and caregivers in France with wellness information and community programs.

1 investor

Biogazelle develops RNA biomarker discovery and transcriptome profiling solutions for clinical research and diagnostics. The company specializes in innovative RNA analysis technologies for medical applications.

1 investor

Biogea develops agrotechnology products based on beneficial fungi and bacteria to increase crop yields for agricultural producers in a sustainable way. The company serves farmers with biological inputs marketed under brands including BIOGROW3 and Nitro Aire.

1 investor

Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.

1 investor

Biogenes Technologies designs, develops, and commercializes animal-free aptamers for use in life science and diagnostics applications.

1 investor

Biognosys provides proteomics contract research services and software for pharma and biotech companies to support R&D, clinical trials, and clinical decision making. It develops mass-spectrometry-based proteomics tools used across drug discovery and clinical development.

1 investor

BioGX is a manufacturer of molecular diagnostic tests. The company is a diagnostic test manufacturer, not a testing laboratory.

1 investor

A community biotechnology laboratory in Ecuador that democratizes access to life sciences education and research. It provides training, workspace, and support for students and entrepreneurs interested in biotechnology and experimental sciences.

1 investor

Imviva is a clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases. The company focuses on creating safer, more effective off-the-shelf cell therapies designed to improve patient access and outcomes in regenerative medicine.

1 investor

BioHive is an organization supporting Utah's life sciences industry, coordinating community, communications, and returnship programs for the sector. It operates in the state of Utah, United States.

1 investor